EPIC-SEC Directors and Industry Panel Discussion: Friday 4/20 6pm-7pm

Friday, April 20
6:00 PM - 7:00 PM
Location: Azalea

H. Vernon Anderson, MD, FACC

Professor of Medicine
University of Texas Health Science Center, McGovern Medical School
University of Texas at Houston, McGovern Medical School

Dr. Anderson is Professor of Medicine in the Cardiology Division at the University of Texas Health Science Center, McGovern Medical School, in Houston. His interests include acute coronary syndromes and ischemic heart disease, as well as clinical outcomes research in all cardiovascular interventions. Dr. Anderson received his medical degree from Emory University, where he also undertook his cardiology and interventional fellowships. He has over 20 years experience as a journal editor: 11 years as Associate Editor of Circulation (1993-2004), and 9 years as Associate Editor of JACC–Cardiovascular Interventions (2008-2017). Dr. Anderson is one of the founders of the ACC-National Cardiovascular Data Registries, and a past member of the ACC-NCDR Management Board, overseeing some of the largest cardiovascular databases in the world. In 2014 he received the Distinguished Service Award form the American College of Cardiology.

Presentation(s):

Send Email for H. Vernon Anderson

Vasilis C. Babaliaros, MD

Emory

Dr Vasilis Babaliaros is Co-Director of the Emory Structural Heart and Valve Center. His expertise includes adult structural and congenital heart disease interventions. Dr Babaliaros has been on the Emory faculty for 10 years.

Presentation(s):

Send Email for Vasilis Babaliaros

Mehmet Cilingiroglu, MD, FSCAI

Arkansas Heart Hospital/University of Arkansas for Medical Sciences
University of Arkansas for Medical Sciences

Dr. Mehmet is a Professor of Medicine at Arkansas Heart Hospital. He is interventional cardiologist over a decade with expertiese in coronary, peripheral as well as structural heart interventions with significant emphasis in interventional cardiology research. His main research interest is in use of OCT in coronary and peripheral circulation as well as novel device development. He has several investigator initiated studies that are funded as he is the leading PI.

Presentation(s):

Send Email for Mehmet Cilingiroglu

Michael J. Cowley, MD, MSCAI

Professor of Medicine
Virginia Commonwealth University
VCU Health System

Presentation(s):

Send Email for Michael Cowley

John S. Douglas, Jr., MD, FSCAI

Professor of Medicine
Emory University School of Medicine
Emory University School of Medicine

Dr John Douglas is a Professor of Medicine in the Cardiology Division of the Emory University School of Medicine and Director of the Interventional Cardiology Fellowship Program at Emory University . He was a partner of the late Andreas Gruentzig and participated in many of the balloon angioplasty and stent trials that formed the basis of modern percutaneous coronary intervention . His primary interests are in performance of complex coronary intervention and the treatment of drug-refractory obstructive hypertrophic cardiomyopathy with the alcohol septal ablation procedure .

Presentation(s):

Send Email for John Douglas

Luis A. Guzman, MD

Director, Cardiovacular Cath Lab
Virginia Commonwealth University

Dr. Luis Guzman is Professor of Medine at Virginia Commonwealth University , Richmond Virginia. He is the medical Director of Cardiac and vacular interventions. He is an interventional cardiologist with over 20 years of experience in the field of coronary and peripheral vascular interventions. His main research interest is oral antiplatelets agents, radial interventions, vascular access complications and high risk and complex coronary interventions. From PAD stand point, main area of interest is critical limb ischemia and complex lowere extremity interventions,

Presentation(s):

Send Email for Luis Guzman

Michael E. Halkos, MD

Associate Professor of Surgery
Emory
Emory University

Dr. Michael E. Halkos is an Associate Professor of Surgery in the Division of Cardiothoracic Surgery at Emory University. He has been a leader in the field of robotic coronary artery bypass and hybrid coronary revascularization and has developed the program at Emory into one of the largest in the country. His other primary interest is in mitral valve surgery, specifically robotic mitral valve surgery. He has an NIH-funded grant in stroke research aimed at reducing stroke after cardiac surgery. He serves as the Associate Program Director for the Integrated Cardiothoracic Surgery Residency Program and is the Scientific Director of the Cardiothoracic Center for Clinical Research.

Presentation(s):

Send Email for Michael Halkos

Michael A. Kutcher, MD, FSCAI

Professor of Cardiovascular Medicine
Wake Forest School of Medicine
Wake Forest School of Medicine

Dr. Michael A. Kutcher is a graduate of Jefferson Medical College, Philadelphia. He did his Internal Medicine Internship and Residency at St. Vincent's Hospital and Medical Center, New York City, followed by a Cardiology Fellowship at Emory University School of Medicine, Atanta. His last half year of Cardiology Fellowship (January to June, 1981) was spent working with Andreas Gruntzig. He was recruited in July 1981 to start the coronary angioplasy program at Bowman Gray School of Medicine, Winston-Salem, NC. He currently is Professor of Cardiovascular Medicine, Interventional Cardiology Faculty, and Director of Cardiovascular Information Services at Wake Forest School of Medicine. He is the primary author or co-author of over 70 peer reviewed publications and has been institutional principal investigator on numerous multi-center trials.

Presentation(s):

Send Email for Michael Kutcher

Massoud A. Leesar, MD, FSCAI

Section head, interventional section
UAB
UAB

Dr. Massoud Leesar is Professor of Medicine in the Cardiology Division of University of Alabama, Birmingham. He is an interventional cardiologist with over 25 years of experience in the field. His main research interest is physiologic evaluation of coronary artery disease, intravsacular imagings. He has published extensively in this area and has conducted many clinical trials.

Presentation(s):

Send Email for Massoud Leesar

Tom C. Nguyen, MD

Director Minimally Invasive Valve Surgery
University of Texas - Memorial Hermann
University of Texas at Houston

Dr. Nguyen specializes in complex adult cardiac, minimally invasive valve surgery, and mitral repair. He is the Director of Minimally Invasive Valve Surgery and Associate Program Director for the cardiothoracic surgery training program. His research interests encompass minimally invasive valve surgery, TAVR, and surgical simulation/education with prior grants from the NIH, TSFRE, and AHA. Dr. Nguyen has received numerous research and teaching awards. He was the past President of the TSRA, resident editor of CTSNet, and member of the ACGME/RRC. Additionally, he is the editor several surgical textbooks. In his spare time, he enjoys traveling and volunteered as a surgeon in Africa (Asmara, Eritrea) for 6 weeks. Recently, he was a recipient of the Houston Business Journal's top 40 under 40 award, the Benjy F. Brooks Outstanding Clinical Faculty Award 2017, Arnold P. Gold Humanism and Teaching Award, and the Houston Business Journal Healthcare Heroes Award. He also received a first-place award from the American College of Cardiology for co-editing a transcatheter handbook.

Presentation(s):

Send Email for Tom Nguyen

Michael Ragosta, MD, FSCAI

Director, Cardiac Catheterization Laboratory
University of Virginia Health System
University of Virginia

Dr. Michael Ragosta is Professor of Medicine and Director of the Cardiac Catheterization Laboratory at the University of Virginia and an Interventional Cardiologist with over 20 years experience. His main clinical interests include clinical hemodynamics, valvular heart disease, transcatheter therapies for aortic stenosis and the percutaneous treatment of high risk and complex coronary artery disease subsets including left main stem intervention, chronic total occlusion and multivessel disease. His research interests are many and include coronary physiology, new percutaneous treatments for valvular and coronary disease and coronary intervention in high risk subsets.

Presentation(s):

Send Email for Michael Ragosta

John P. Reilly, MD, FSCAI

Vice Chair, Department of Cardiology
Ochsner Medical Center

Presentation(s):

Send Email for John Reilly

Habib Samady, MD, FSCAI

Professor of Medicine
Emory University School of Medicine
Emory University School of Medicine

Dr. Samady trained in general cardiology, nuclear cardiology and interventional cardiology at Yale University School of Medicine from 1994 to 1999. He was Assistant Professor of Medicine at University of Virginia from 1999-2003 and Clinical Associate Professor of Medicine at Eastern Virginia Medical School from 2003-2005. He joined the Division of Cardiology at Emory University in 2005. In 2009, he became Professor of Medicine and in 2011, Director of Interventional Cardiology at Emory University and Director of the Cardiac Catheterization Laboratory of EUH. He has supervised and participated in the training of over 60 interventional cardiology fellows and over 100 general cardiology fellows.

Presentation(s):

Send Email for Habib Samady

Rick A. Stouffer, MD, FSCAI

Professor of Medicine
University of North Carolina
University of North Carolina School of Medicine

George 'Rick' Stouffer, MD is the Henry A. Foscue Distinguished Professor of Medicine and Chief of Cardiology at the University of North Carolina. He received degrees in Mechanical Engineering and Mathematics from Bucknell University and an MD degree from the University of Maryland School of Medicine. He completed internal medicine residency, cardiology fellowship, and interventional cardiology fellowship at the University of Virginia and was on the faculty at the University of Texas Medical Branch prior to going to UNC. Dr. Stouffer's research is in smooth muscle cell growth regulation, the role of the cytoskeleton in regulating signaling pathways, thrombin generation, myocardial infarction occurring in hospitalized patients and renal artery stenosis.

Presentation(s):

Send Email for Rick Stouffer

Angela M. Taylor, MD, MS

Associate Professor of Caridology
University of Virginia
University of Virginia

Dr. Angela Taylor is an Associate Professor in Cardiology at the University of Virgina. She practices clinically as an interventional cardiologist and as director of the Cardiometabolic Network which provides care for high risk patients with diabetes and cardiovascular disease with a lifestyle focus. She also co-directs a clinical and translational research program and her main research areas of interest are coronary microvascular disease, immune mechanisms of atherosclerosis, and coronary disease associated with diabetes and women.

Presentation(s):

Send Email for Angela Taylor

Khaled M. Ziada, MD, FACC, FSCAI

Clinical Chief of Cardiology. Director, Cardiovascular Interventional Fellowship
Gill Heart Institute, University of Kentucky
Gill Heart & Vascular Institute and University of Kentucky Medical School

Dr. Khaled Ziada is a Professor of Medicine and an Endowed Gill Foundation Professor of Interventional Cardiology at the Gill Heart Institute of the University of Kentucky. He serves as the enterprise medical director of interventional services and director of the cardiovascular interventional fellowship program. He has been practicing interventional cardiology and peripheral endovascular therapeutics for more than 12 years. His research interests include revascularization techniques, antiplatelet therapy, and clinical outcomes. He has intense interest in quality assurance and improvement of coronary interventions, with particular emphasis on regional practices and outcomes of primary PCI. He is the principal investigator of the ACCELERATOR regional system of care for STEMI in central and eastern KY, a grant offered by the AHA in collaboration with the Duke Clinical Research Institute. He also directs the clinical research program of the Gill Heart Insitute and as such is the local principal investigator of many national and international trials.

Presentation(s):

Send Email for Khaled Ziada

Martyn R. Thomas, MD

VP of Medical Affairs
Edwards LIfesciences

• Dr Martyn Thomas Biography
• DR M R Thomas MD FRCP
• Qualified from St Bartholomews Hospital, London 1982.
• Trained in Cardiology at Kings College Hospital, London.
• Became Director of Cardiology Services at Kings College Hospital from 2003 to 2006
• Moved to St Thomas Hospital London in 2007. Director of Cardiovascular Services St Thomas’ Hospital 2007 to October 2014.
• President British Cardiovascular Intervention Society (BCIS) 2004-2008.
• Performed the first case of Edwards Sapien Valve implantation in the United Kingdom.
• Previous co-PI of the SOURCE Registries of TAVI using the Edwards Sapien THV device.
• Chairman and founder of PCR London Valves and Member of the PCR Board.
• Programme committee member of TCT and TVT.
• Multiple publications in pier reviewed journals on the topic of TAVI.
• Lead of team who performed first 3 cases of the Edwards Fortis Mitral Valve implants in the world in February 2014.
• Left practice in October 2014 to become VP of Medical Affairs at Edwards Lifesciences.
• Relocated to Southern California on Jan 8th 2015!!

Presentation(s):

Send Email for Martyn Thomas

Chuck Simonton, MD

Divisional Vice President, Global Medical Affairs, Chief Medical Officer
Abbott

Dr. Chuck Simonton is the Chief Medical Officer & Divisional Vice President of Global Medical Affairs for Abbott Vascular. His role with Abbott Vascular includes evaluating & testing new internal devices in development; advising pre-market clinical research across clinical science, legal and regulatory groups; defining the global strategy & structure of all post-market clinical research; assessing new business development opportunities; medical oversight of commercial product performance & safety; and continuing his interest in the education of interventional vascular physicians by establishing a diversified medical sciences department.

Presentation(s):

Send Email for Chuck Simonton

Francesco Franchi, MD

Assistant Professor, Division of Cardiology
University of Florida - Jacksonville
University of Florida - Jacksonville, Division of Cardiology

Francesco Franchi, MD is an Assistant Professor of Medicine at the Division of Cardiology of University of Florida College of Medicine-Jacksonville, USA. He received his medical degree summa cum laude from the Medical School of the University of Modena and Reggio Emilia (Italy), where he also completed the fellowship in cardiovascular diseases and a research fellowship in cardiology. He started his research experience at the University of Florida in 2012 as post-doctoral research fellow. He is Attending Cardiologist at the University of Florida Health System since 2016. His areas of interest and research are thrombosis, coronary artery diseases, and acute coronary syndromes. Dr. Franchi is currently involved in studying the pharmacodynamic profile and efficacy of the newer antiplatelet and antithrombotic drugs. He is an author of peer-reviewed articles, abstracts, and book chapters in the field.

Presentation(s):

Send Email for Francesco Franchi

Andres M. Pineda Maldonado, MD, FACC

University of Florida College of Medicine - Jacksonville
University of Florida College of Medicine - Jacksonville

Presentation(s):

Send Email for Andres Pineda Maldonado

Rick Hillstead, PhD, FAHA

Georgia Venture Partners

Rick Hillstead, PhD, FAHA, has been actively involved in the design and development of medical devices since 1983. He held several Product Research and Development positions with Cordis Corporation (Johnson & Johnson) where he pioneered device development in the Cordis Coronary Stent program as a Senior Research Engineer. He then directed new technology development for Novoste Corporation, focusing on intravascular brachytherapy for the treatment of coronary restenosis. He was a founding member of The Innovation Factory (TIF), a private medical device incubator, and a founding member in Accuitive Medical Ventures I and II (2004 – 2007). He is currently a partner with Georgia Venture Partners. He frequently serves as an expert witness worldwide in litigations relating to interventional cardiology devices. Dr. Hillstead also sits on the New Technology Advisory Board at Emory University.

Presentation(s):

Send Email for Rick Hillstead

Alex Nepogodiev

Global Marketing Director
Medtronic

Presentation(s):

Send Email for Alex Nepogodiev

Brian Walsh

Innova Group

Presentation(s):

Send Email for Brian Walsh


Assets

EPIC-SEC Directors and Industry Panel Discussion: Friday 4/20 6pm-7pm



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for EPIC-SEC Directors and Industry Panel Discussion: Friday 4/20 6pm-7pm